Long-term evaluation of lipid profile and oral glucose tolerance test in Norplant® users

被引:1
作者
Araujo, FF [1 ]
de Lima, GR [1 ]
Guazzelli, CAF [1 ]
Barbieri, M [1 ]
Vigorito, NM [1 ]
Lindsey, PC [1 ]
Baracat, EC [1 ]
机构
[1] Univ Fed Sao Paulo, Dept Obstet & Gynecol, Escola Paulista Med, Sao Paulo, Brazil
关键词
levonorgestrel; subdermal contraceptive; Norplant (R); cholesterol; lipids; OGTT; diabetes;
D O I
10.1016/j.contraception.2005.10.018
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose: This Study reports the results of the lipid profile and oral glucose tolerance test (OGTT) in 46 normal patients tested before and after 5 years of Norplant use. Results: After 5 years, there was a Substantial decrease of 28.9% in high-density lipoprotein cholesterol levels and a similar but less pronounced fall of 7.1% in the total cholesterol levels. The Castelli 1 index did not vary, and the triglycerides and low-density lipoprotein cholesterol levels remained normal and unchanged throughout the study period. All the mean values of OGTT were significantly lower after 5 years, except for the 90-min glycemia. Conclusion: These findings indicate that long-term Norplant use does not increase cardiovascular risks. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:361 / 363
页数:3
相关论文
共 18 条
[1]   SERUM-LIPIDS IN NORPLANT IMPLANTS USERS - A CROSS-SECTIONAL STUDY [J].
AFFANDI, B ;
SUHERMAN, SK ;
DJAJALELANA ;
PRIHARTONO, J ;
LUBIS, F ;
SAMIL, RS .
CONTRACEPTION, 1987, 36 (04) :429-434
[2]  
CASTELLI WP, 1988, AM J OBSTET GYNECOL, V158, P1553, DOI 10.1016/0002-9378(88)90189-5
[3]   SUMMARY ESTIMATES OF CHOLESTEROL USED TO PREDICT CORONARY HEART-DISEASE [J].
CASTELLI, WP ;
ABBOTT, RD ;
MCNAMARA, PM .
CIRCULATION, 1983, 67 (04) :730-734
[4]   FERTILITY CONTROL IN WOMEN WITH A PROGESTOGEN RELEASED IN MICROQUANTITIES FROM SUBCUTANEOUS CAPSULES [J].
CROXATTO, H ;
DIAZ, S ;
VERA, R ;
ETCHART, M ;
ATRIA, P .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1969, 105 (07) :1135-&
[5]  
DARNEY PD, 1994, AM J OBSTET GYNECOL, V170, P1536
[6]   Metabolic effects of implantable steroid contraceptives for women [J].
Dorflinger, LJ .
CONTRACEPTION, 2002, 65 (01) :47-62
[7]  
FAUNDES A, 1984, PROTOCOLO PESQUISA E, P12
[8]   Norplant® consensus statement and background review [J].
Fraser, IS ;
Tiitinen, A ;
Affandi, B ;
Brache, V ;
Croxatto, HB ;
Diaz, S ;
Ginsburg, J ;
Gu, SJ ;
Holma, P ;
Johansson, E ;
Meirik, O ;
Mishell, DR ;
Nash, HA ;
von Schoultz, B ;
Sivin, I .
CONTRACEPTION, 1998, 57 (01) :1-9
[9]   CHANGES IN CARBOHYDRATE-METABOLISM DURING 30 MONTHS ON NORPLANT [J].
KONJE, JC ;
OTOLORIN, EO ;
LADIPO, OA .
CONTRACEPTION, 1991, 44 (02) :163-172
[10]   THE EFFECT OF CONTINUOUS SUBDERMAL LEVONORGESTREL (NORPLANT) ON CARBOHYDRATE-METABOLISM [J].
KONJE, JC ;
OTOLORIN, EO ;
LADIPO, OA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (01) :15-19